Enhancing Oncology exploration with Integrated KRAS Assay solutions and RAS Assays
while in the fast evolving industry of oncology investigate, precise and economical mutation screening is very important for building qualified therapies. The KRAS Services System performs a pivotal job On this landscape by offering complete answers for KRAS mutation profiling and Evaluation. KRAS mutations, present in close to ninety five% of RAS-